News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,273 Results
Type
Article (39551)
Company Profile (247)
Press Release (656475)
Section
Business (204101)
Career Advice (2007)
Deals (35412)
Drug Delivery (94)
Drug Development (81009)
Employer Resources (172)
FDA (16155)
Job Trends (14843)
News (345044)
Policy (32499)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2546)
Accelerated approval (4)
Adcomms (20)
Allergies (80)
Alliances (49369)
ALS (83)
Alzheimer's disease (1354)
Antibody-drug conjugate (ADC) (109)
Approvals (16157)
Artificial intelligence (230)
Autoimmune disease (16)
Automation (14)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (18)
Biosimilars (101)
Biotechnology (175)
Bladder cancer (58)
Brain cancer (25)
Breast cancer (249)
Cancer (2009)
Cardiovascular disease (162)
Career advice (1673)
Career pathing (29)
CAR-T (140)
Cell therapy (396)
Cervical cancer (19)
Clinical research (65727)
Collaboration (768)
Compensation (463)
Complete response letters (19)
COVID-19 (2581)
CRISPR (35)
C-suite (211)
Cystic fibrosis (98)
Data (1977)
Decentralized trials (2)
Denatured (16)
Depression (38)
Diabetes (249)
Diagnostics (6336)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (112)
Drug pricing (95)
Drug shortages (25)
Duchenne muscular dystrophy (85)
Earnings (86213)
Editorial (31)
Employer branding (21)
Employer resources (146)
Events (111686)
Executive appointments (647)
FDA (17270)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (687)
Gene editing (96)
Generative AI (18)
Gene therapy (278)
GLP-1 (685)
Government (4380)
Grass and pollen (4)
Guidances (49)
Healthcare (18808)
Huntington's disease (22)
IgA nephropathy (23)
Immunology and inflammation (103)
Indications (26)
Infectious disease (2713)
Inflammatory bowel disease (132)
Inflation Reduction Act (8)
Influenza (48)
Intellectual property (87)
Interviews (311)
IPO (16484)
IRA (40)
Job creations (3628)
Job search strategy (1422)
Kidney cancer (9)
Labor market (34)
Layoffs (454)
Leadership (15)
Legal (7900)
Liver cancer (70)
Lung cancer (292)
Lymphoma (134)
Machine learning (4)
Management (58)
Manufacturing (267)
MASH (61)
Medical device (13325)
Medtech (13330)
Mergers & acquisitions (19403)
Metabolic disorders (632)
Multiple sclerosis (72)
NASH (16)
Neurodegenerative disease (80)
Neuropsychiatric disorders (24)
Neuroscience (1835)
NextGen: Class of 2025 (6512)
Non-profit (4476)
Northern California (2438)
Now hiring (37)
Obesity (340)
Opinion (201)
Ovarian cancer (72)
Pain (77)
Pancreatic cancer (76)
Parkinson's disease (135)
Partnered (20)
Patents (204)
Patient recruitment (96)
Peanut (46)
People (57095)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20470)
Phase II (28943)
Phase III (21572)
Pipeline (1052)
Podcasts (45)
Policy (113)
Postmarket research (2563)
Preclinical (8657)
Press Release (64)
Prostate cancer (94)
Psychedelics (30)
Radiopharmaceuticals (244)
Rare diseases (359)
Real estate (5901)
Recruiting (65)
Regulatory (22146)
Reports (46)
Research institute (2318)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (39)
Schizophrenia (64)
Series A (120)
Series B (78)
Service/supplier (11)
Sickle cell disease (51)
Southern California (2111)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (28)
Startups (3571)
State (2)
Stomach cancer (13)
Supply chain (59)
The Weekly (27)
United States (21247)
Vaccines (657)
Venture capitalists (37)
Webinars (12)
Weight loss (224)
Women's health (33)
Worklife (15)
Date
Today (122)
Last 7 days (691)
Last 30 days (2718)
Last 365 days (33566)
2025 (8171)
2024 (35218)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (49)
Alaska (7)
Arizona (224)
Arkansas (13)
Asia (37709)
Australia (6165)
California (5552)
Canada (1873)
China (475)
Colorado (247)
Connecticut (256)
Delaware (128)
Europe (80859)
Florida (825)
Georgia (194)
Idaho (57)
Illinois (498)
India (24)
Indiana (291)
Iowa (9)
Japan (142)
Kansas (100)
Kentucky (23)
Louisiana (7)
Maine (61)
Maryland (831)
Massachusetts (4180)
Michigan (209)
Minnesota (370)
Mississippi (2)
Missouri (77)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1587)
New Mexico (28)
New York (1599)
North Carolina (921)
North Dakota (7)
Northern California (2438)
Ohio (192)
Oklahoma (14)
Oregon (33)
Pennsylvania (1259)
Puerto Rico (9)
Rhode Island (26)
South America (1094)
South Carolina (18)
South Dakota (1)
Southern California (2111)
Tennessee (93)
Texas (830)
Utah (164)
Virginia (130)
Washington D.C. (57)
Washington State (513)
West Virginia (3)
Wisconsin (49)
696,273 Results for "kardium inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Kardium Announces $104M in New Financing for Innovative Atrial Fibrillation Treatment
Kardium Inc., developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, has raised US $104 million in a new financing round.
June 11, 2024
·
2 min read
Kardium Announces Completion of Paroxysmal Enrollment in the PULSAR IDE Study
Kardium Inc. announced today the successful completion of enrollment in the paroxysmal cohort of the pivotal PULSAR IDE (Investigational Device Exemption) study.
April 2, 2024
·
3 min read
Kardium Announces Enhanced Clinical Capabilities of the Globe® System With Right Atrial Ablation and Hybrid Energy Ablation
Kardium Inc., a private medical device company that has developed the Globe® System for the treatment of atrial fibrillation, announced that it had successfully treated a series of patients delivering therapy in both the left and right atria.
May 9, 2024
·
3 min read
Kardium announces positive 1-year outcomes for PULSE-EU trial with the Globe® System, showing promise for improving the treatment of atrial fibrillation
Kardium announces positive 1-year outcomes for PULSE-EU trial with the Globe ® System, showing promise for improving the treatment of atrial fibrillation.
May 29, 2024
·
2 min read
Kardium Announces First US Procedures in PULSAR Study of Globe® Pulsed Field System
Kardium Inc., a private medical device company that has developed the Globe System for the treatment of atrial fibrillation (AF) using pulsed field ablation (PFA), announced today that the first US patients have been successfully treated in the PULSAR clinical study.
May 31, 2023
·
2 min read
Successful First-in-Human Clinical Study of Kardium’s Next Generation Globe® Pulsed Field System
Kardium Inc. announces the successful first-in-human study of its next generation Globe® Pulsed Field System to treat atrial fibrillation (AF) using pulsed field ablation (PFA) therapy.
November 8, 2022
·
3 min read
Kardium Announces First Patients Treated in PULSAR IDE Study of Globe® Pulsed Field System
Kardium Inc., a private medical device company that has developed the Globe® PF System for the treatment of atrial fibrillation (AF) using pulsed field ablation (PFA), announced today that the first patients have been successfully treated in its PULSAR clinical study.
March 15, 2023
·
3 min read
First-in-Human Trial of Pulsed Field Ablation with Kardium’s Globe® PF System
Kardium Inc. announces the completion of successful first-in-human procedures with the Globe Pulsed Field System.
December 15, 2021
·
2 min read
Press Releases
FOXO TECHNOLOGIES INC. ANNOUNCES EXECUTION OF A NON BINDING AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
March 20, 2025
·
4 min read
Press Releases
Alcon Agrees to Acquire LENSAR, Inc.
March 25, 2025
·
9 min read
1 of 69,628
Next
